Skip to content

The effect of Chicory-Fumitory Syrup and megestrol in hot flashes

Comparison of the Effect of Chicory-Fumitory Syrup and megestrol in hot flashes in prostate cancer patients

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190112042333N1
Enrollment
72
Registered
2019-01-26
Start date
2019-01-21
Completion date
Unknown
Last updated
2019-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer, Hot flashes. Malignant neoplasm of prostate

Interventions

Intervention 1: Intervention group (1): Chicory and Fumitory Syrup contains hydro alcoholic extracts of Chicory and Fumitory with dosage of 7 mil/ daily divided to 2 doses. Intervention 2: Interventio

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Age above 18 To be a prostate cancer patient To be under ADT therapy and complaining hot flashes

Exclusion criteria

Exclusion criteria: Metastatic Cancer Liver or kidney disorders Being under treatment for hot flashes

Design outcomes

Primary

MeasureTime frame
The number of hot flashes: average of frequency during a week according to based on Daily Diary of Hot flashes. Timepoint: Daily. Method of measurement: Calculation the average of frequency of hot flashes in a week.;Severity of hot flashes: average of severity during a week according to based on Daily Diary of Hot flashes. Timepoint: Daily. Method of measurement: Calculation the average of severity scores of hot flashes in a week.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSajjad Sadeghi

Shahid Beheshti University of Medical Sciences

drsadeghi@sbmu.ac.ir+98 21 8877 3521

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026